This inventor holds 1 USPTO granted patent. Top assignee: Laboratories Negma. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: The Innovations of Jean-Claude Fruchart
Introduction
Jean-Claude Fruchart is a notable inventor based in Ennetières en Weppes, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to the use of 7-acyl benzoxazinones and their derivatives in treating various medical conditions. His work has the potential to impact the medical community positively.
Latest Patents
Fruchart holds a patent for the use of 7-acyl benzoxazinones and their derivatives, which are characterized by a specific general formula. This invention relates to pharmaceutical compositions that can be administered orally, containing these compounds in association with a pharmaceutically acceptable vehicle. These products are useful as medicaments, showcasing Fruchart's commitment to advancing medical treatments.
Career Highlights
Jean-Claude Fruchart is associated with Laboratories Negma, where he has been able to apply his expertise in developing innovative pharmaceutical solutions. His career reflects a dedication to research and development in the pharmaceutical industry, contributing to advancements that can improve patient care.
Collaborations
Fruchart has worked alongside talented colleagues such as Isabelle Lesieur and Charles Lespagnol. Their collaborative efforts have likely enhanced the research and development processes within their organization, leading to innovative solutions in the pharmaceutical field.
Conclusion
Jean-Claude Fruchart's contributions to the pharmaceutical industry through his patent and collaborative work highlight his role as an influential inventor. His innovations have the potential to make a significant impact on medical treatments, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile